Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.
Skip to main content

Fifty years of HIV: how close are we to a cure?

It’s half a century since the first known HIV-related death and two patients appear to have been cured of the virus. What does this mean for the 37 million still living with it?

HIV remission achieved in second patient

A second person has experienced sustained remission from HIV-1 after ceasing treatment, reports a paper led by researchers at UCL and Imperial College London.

Oxford University signs universal flu vaccine development deal with US startup BWV

Oxford University, through its innovation arm Oxford University Innovation (OUI), has entered into an option agreement for a universal influenza vaccine with US-based startup Blue Water Vaccines (BWV), which is raising $15m to support development of the flu shot. Further information is available here.

CHERUB HIV Garden at the RHS Chelsea Flower Show 2018

The CHERUB HIV garden is a landmark project for, and about, people living with HIV. It was launched at the RHS Chelsea Flower Show 2018 and then moved to a permanent site in Brent.

Medawar Day - 4 October 2018

The main aim of Medawar Day is to have one day where the different labs can share their work and we can all get some sense of what is going on – it is not a huge building but it is still easy to miss out.

Genetic study reveals how hepatitis C interacts with humans

A big data study of hepatitis C and more than 500 patients with the virus has opened the way for a better understanding of how the virus interacts with its human hosts.

Targeting HIV ‘reservoir’ could be first step to understanding how to cure the disease

A new clinical trial will test whether it is possible to destroy hidden reservoirs of HIV virus that are a key obstacle to curing the disease.

HIV evolving 'into milder form'

HIV is evolving to become less deadly and less infectious, according to a major scientific study. The team at the University of Oxford, lead by Prof Philip Goulder, shows the virus is being "watered down" as it adapts to our immune systems.

World hepatitis day 2014

Hepatitis is a viral infection that causes acute and chronic disease, and sometimes death. World hepatitis day takes place each year on 28th July and the aim of this year’s World Health Organization’s campaign is to raise awareness of viral hepatitis.

Medawar building website re-launch

The Peter Medawar Building for Pathogen Research website has been re-vamped and re-launched! We hope that you will find the new site accessible and helpfull.

First trial of a new hepatitis C vaccine shows promise

A new vaccine against the chronic liver disease hepatitis C has shown promising results in a first clinical trial in humans, Oxford University reports. Professor Paul Klenerman is one of the lead researchers on this study.

Early HIV treatment may slow disease progression

A 48-week course of antiretroviral medication taken in the early stages of HIV infection slows the damage to the immune system and delays the need for long term treatment, according to research published today in the New England Journal of Medicine. However, the delay was only marginally longer than the time already spent on treatment.

UK scientists to begin trial of potential HIV cure

Scientists and clinicians from five leading UK universities will begin a groundbreaking clinical trial next year to test a possible cure for HIV infection. The researchers, led by Dr John Frater at Oxford University and Dr Sarah Fidler at Imperial College London, hope the trial will show that a cure is feasible.